Current Rating Overview and Context
MarketsMOJO assigned a 'Sell' rating to TTK Healthcare Ltd. on 21 July 2025, reflecting a decline in the company’s overall Mojo Score from 55 to 42. This rating indicates a cautious stance towards the stock, suggesting that investors may want to consider reducing exposure or avoiding new purchases at current levels. The 'Sell' grade is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. It is important to note that while the rating was set last year, the data and performance figures presented here are current as of 17 June 2026, ensuring relevance for today’s market conditions.
Quality Assessment: Average Fundamentals Amidst Growth Challenges
As of 17 June 2026, TTK Healthcare’s quality grade is assessed as average. The company has demonstrated modest growth over the past five years, with net sales increasing at an annualised rate of 7.60%. However, operating profit growth has been notably subdued, expanding at just 1.48% annually during the same period. This sluggish profitability growth raises concerns about the company’s ability to scale earnings effectively.
The latest half-year data ending March 2026 reveals a return on capital employed (ROCE) of 7.86%, which is relatively low and signals limited efficiency in generating returns from invested capital. Additionally, the quarterly profit after tax (PAT) stood at ₹19.18 crores but declined by 6.4%, indicating pressure on the company’s bottom line. A significant portion of profit before tax (PBT), 68.27%, is derived from non-operating income, which may not be sustainable and suggests reliance on ancillary sources rather than core operations.
Valuation: Attractive but Reflective of Underperformance
TTK Healthcare’s valuation grade is currently attractive, implying that the stock trades at a relatively low price compared to its earnings and book value metrics. This valuation attractiveness may appeal to value-oriented investors seeking bargains in the microcap segment. However, the low valuation also reflects the market’s cautious view of the company’s growth prospects and financial health. The subdued growth and profitability trends have likely contributed to the discounted price levels.
Financial Trend: Flat Performance with Underlying Weaknesses
The financial trend for TTK Healthcare is flat, indicating a lack of significant improvement or deterioration in recent quarters. The company’s results for March 2026 were largely stagnant, with no meaningful growth in key financial indicators. This stagnation is compounded by the weak profitability metrics and the high proportion of non-operating income contributing to profits, which may not be a reliable source of earnings going forward.
Technicals: Mildly Bearish Momentum
From a technical perspective, the stock exhibits mildly bearish signals. Price movements over various time frames show mixed results: a 0.90% gain in the last day and a 1.02% increase over the past week contrast with a 0.88% decline over the last month and a sharper 14.94% drop over six months. Year-to-date, the stock has fallen by 14.16%, and over the last year, it has delivered a negative return of 29.06%. This consistent underperformance against the BSE500 benchmark over the past three years underscores the stock’s weak technical momentum and investor sentiment.
Investor Sentiment and Market Positioning
Despite its microcap status, TTK Healthcare has attracted minimal interest from domestic mutual funds, which hold only 0.01% of the company. Given that mutual funds typically conduct thorough on-the-ground research, their limited stake may indicate reservations about the company’s valuation or business outlook. This lack of institutional confidence further supports the cautious 'Sell' rating.
Summary for Investors
In summary, TTK Healthcare Ltd.’s current 'Sell' rating by MarketsMOJO reflects a combination of average quality fundamentals, attractive but potentially justified valuation, flat financial trends, and mildly bearish technical indicators. The company’s modest growth, low profitability, and reliance on non-operating income raise concerns about sustainable earnings growth. Meanwhile, the stock’s consistent underperformance relative to benchmarks and limited institutional interest suggest that investors should approach with caution.
For investors, this rating implies that TTK Healthcare may not be an ideal candidate for portfolio accumulation at present. Those holding the stock might consider reassessing their positions in light of the company’s current financial health and market dynamics. Conversely, value investors may monitor the stock for any signs of fundamental improvement or technical reversal before considering entry.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Looking Ahead
Investors should continue to monitor TTK Healthcare’s quarterly results and market developments closely. Key indicators to watch include improvements in operating profit growth, a reduction in reliance on non-operating income, and any positive shifts in return ratios such as ROCE. Additionally, changes in institutional ownership or technical momentum could signal evolving market sentiment.
Until such improvements materialise, the 'Sell' rating remains a prudent reflection of the company’s current challenges and market positioning. This rating serves as a guide for investors to prioritise capital allocation towards stocks with stronger fundamentals and more favourable growth trajectories.
About MarketsMOJO Ratings
MarketsMOJO’s rating system integrates multiple dimensions of stock analysis, including quality of earnings, valuation metrics, financial trends, and technical chart patterns. The 'Sell' rating indicates that the stock is expected to underperform relative to the broader market or its sector peers, signalling investors to exercise caution. This comprehensive approach helps investors make informed decisions based on a balanced assessment of quantitative and qualitative factors.
Stock Snapshot as of 17 June 2026
TTK Healthcare Ltd. currently holds a Mojo Score of 42.0, reflecting its 'Sell' grade. The stock has experienced a 0.90% gain in the last trading day, but longer-term returns remain negative, with a 29.06% decline over the past year. The company’s microcap status and diversified sector classification position it as a smaller player with limited institutional backing.
Investors should weigh these factors carefully when considering TTK Healthcare as part of their portfolio strategy.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
